Affiliation:
1. Department of Epidemiology, Laboratories and Research
2. OPS/OMS
3. National Laboratory of Public Health
Abstract
Abstract
Background: Healthcare workers are an exposed group for SARS-CoV-2, and this exposure is a public health priority. Transmission can occur from infected patients to staff and from infected staff to patients and co-workers, thus undermining the health care system. This study estimated the seroprevalence in this population and identified some associated factors.
Methods: We analyzed the exposure of healthcare workers in ten (10) large hospitals providing care to patients with COVID-19 by testing for antibodies to SARS-CoV-2. Potential risk factors such as age, vaccination history, and barrier measures such as masking were explored through a questionnaire.
Results: From December 06 to 15, 2021, among 3743 health care workers in major hospitals providing care to patients with COVID-19, a sample of 566 had received serological testing for SARS-CoV-2. The mean age was 39 years, 62% were female, and approximately 12% had hypertension. The vast majority did not reveal any signs or symptoms compatible with COVID-19, and 62% had already received the anti-COVID-19 vaccine.
The national prevalence regardless of vaccination status was 44%, with a predominance of male gender, age group 60 and older, and the Western Department. The prevalenceamong unvaccinated persons was 11.59%, and never wearing masks was associated with an increased risk of developing antibodies to SARS-CoV-2.
Conclusion: Among health care workers, COVID-19 affects both sexes with a female predominance. The age group over 60 years is the most affected, and not wearing a mask is a risk factor associated with virus detection.
Publisher
Research Square Platform LLC
Reference21 articles.
1. Organisation mondiale de la Santé. Protocole d’enquête séroépidémiologique sur l’infection par le virus de la COVID-19 par tranche d’âge dans la population, 17 mars 2020 [Internet]. Organisation mondiale de la Santé; 2020 [cited 2022 Apr 26]. Report No.: WHO/2019-nCoV/Seroepidemiology/2020.1. Available from: https://apps.who.int/iris/handle/10665/331526.
2. COVID-19 étude population (SEROCoV-POP). - Etude de l’Unité d’épidémiologie populationnelle (UEP) | HUG - Hôpitaux Universitaires de Genève [Internet]. [cited 2022 Apr 26]. Available from: https://www.hug.ch/medecine-premier-recours/covid-19-etude-population-serocov-pop.
3. Coronavirus disease (COVID-19). : Serology, antibodies and immunity [Internet]. [cited 2022 Apr 26]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-serology.
4. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic;Venugopal U;Int J Infect Dis,2021
5. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020;Bajema KL;JAMA Intern Med,2021